"We need to do something big and bold now!...We need to do
"We need to do something big and bold now!...We need to do something now while we still can."
Well yes, that sounds amazing and I am with you, however what do you suggest? Such language without ideas leaves one angry, frustrated, and still sitting on the couch.
Truth is, based on CYDY's own design of the trial, it failed to meet its primary endpoints. Forget that we hit our secondary endpoints and that we were not allowed to change protocol to 4 injections which we now know would have most likely gotten us to the primary endpoints. CYDY did not hit its mark by its own design and the FDA is "simply following orders" and clearly not thinking outside the box here in the slightest.
I agree with you that if this spooks our foreign ties in connection with covid, it's game over unless/until the Brazil trials show something meaningful. And yes, sadly, I agree with you that it is pretty damn clear right now that the FDA is not going to treat CYDY fairly when it comes to HIV, NASH, Cancer, or anything else. Does that mean we give up and sell? Well, I for one don't think so. Then again, I am not doubling down right now either, despite the share price as I write this ($1.93). Hell...I hope not buying more right now looks like a crap decision in hindsight in the not too distant future!
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Top 5 Most Recently Viewed Articles
Hygenco Partners with REC for Green Ammonia Initiative Hygenco Green Energies Pvt Ltd, recognized for its innovative methods in producing cost-effective green hydrogen, has recently entered into a Memorandum of Understanding (MOU) with REC Limited, previously referred to as the Rural Electrification Corporation Limited. This collaboration is geared towards financing...
Continue Reading
Unilumin's Revolutionary Transformation into AI Services Shenzhen, China has become a hub for innovation as Unilumin Group celebrates a significant milestone. Recently, the company hosted a momentous event that marked its transition from a traditional display hardware supplier to an advanced AI intelligent service application provider. AI Forum Celebrating Visionary...
Continue Reading
Asiacell Unveils Strategic Collaboration with Google Cloud Asiacell, a notable player in the telecommunications industry, has embarked on an exciting journey by collaborating with Google Cloud. This partnership is set to transform how businesses and educational institutions in Iraq leverage technology by introducing cutting-edge digital tools. Introduction of Google...
Continue Reading
Experience Architectural Innovation with Dwell The upcoming event by Dwell invites design enthusiasts to engage with three exceptional residences and the renowned Hollyhock House, designed by architectural legend Frank Lloyd Wright. This unique experience will highlight the creativity and contemporary approach prevalent in modern residential architecture. Exclusive Home...
Continue Reading
Swift Textile Metalizing Marks Ten Years of Supplier Honors STM proudly announces that its Advance Defense Solutions Division has been recognized with Lockheed Martin's elite honors over the past ten years. This includes the prestigious "Elite Supplier", "Star Supplier", and "Ahead of Ready" awards, showcasing a deep commitment to quality in delivery and service....
Continue Reading